Val-9Ala and Ile+58Thr polymorphism of MnSOD in Parkinson's disease

Clinical Biochemistry

Volumn 43, Issue 12, 2010, Pages 979-982

  Wang, Vinchi ^a,b   Chen, Shao Yuan ^a   Chuang, Tzu Chao ^c   Shan, Din E ^d,e   Soong, Bing Wen ^d,e   Kao, Ming Ching ^f  

^a CARDINAL TIEN HOSPITAL   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^c TAMKANG UNIVERSITY   (Taiwan)

^d TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^e NATIONAL YANG MING UNIVERSITY   (Taiwan)

^f CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Genetic polymorphism; Mn SOD; Parkinson disease

Indexed keywords

ALANINE; AMINO ACID; GENOMIC DNA; ISOLEUCINE; MANGANESE SUPEROXIDE DISMUTASE; MITOCHONDRIAL ENZYME; THREONINE; VALINE; SUPEROXIDE DISMUTASE;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; BRAIN MITOCHONDRION; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; ENZYMOLOGY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SUPEROXIDE DISMUTASE;

EID: 77954315710     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2010.05.009     Document Type: Article

References (37)

1. Shimoda-Matsubayashi S., Matsumine H., Kobayashi T., Nakagawa-Hattori Y., Shimizu Y., Mizuno Y. Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene: A predictive evidence for conformational change to influence mitochondrial transport and a study of allelic association in Parkinson's disease. Biochem Biophys Res Commun 1996, 226:5615.
2. Shimoda-Matsubayashi S., Hattori T., Matsumine H., Shinohara A., Yoritaka A., Mori H., et al. Mn SOD activity and protein in a patient with chromosome 6-linked autosomal recessive parkinsonism in comparison with Parkinson's disease and control. Neurology 1997, 49:1257-1262.
3. Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentai A., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993, 362:59-62.
4. Li Y., Huang T.T., Carlson E.J., Melov S., Ursell P.C., Olson J.L., et al. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat Genet 1995, 11:376-381.
5. Huang T.T., Carlson E.J., Kozy H.M., Mantha S., Goodman S.I., Ursell P.C., et al. Genetic modification of prenatal lethality and dilated cardiomyopathy in Mn superoxide dismutase mutant mice. Free Radic Biol Med 2001, 31:1101-1110.
6. Li H., Kantoff P.W., Giovannucci E., Leitzmann M.F., Gaiano J.M., Stampfer M.J., et al. Manganese superoxide dismutase polymorphism, prediagnostic antioxidant status, and risk of clinical significant prostate cancer. Cancer Res 2005, 65:2498-2504.
7. Nomiyama T., Tanaka Y., Piao L., Nagasaka K., Sakai K., Ogihara T., et al. The polymorphism of manganese superoxide dismutase is associated with diabetic nephropathy in Japanese type 2 diabetic patients. J Hum Genet 2003, 48:138-141.
8. Hinerfeld D., Traini M.D., Weinberger R.P., Cochran B., Doctrow S.R., Harry J., et al. Endogenous mitochondrial oxidative stress: neurodegeneration, proteomic analysis, specific respiratory chain defects, and efficacious antioxidant therapy in superoxide dismutase 2 null mice. J Neurochem 2004, 88:657-667.
9. Kim G.W., Kondo T., Noshita N., Chan P.H. Manganese superoxide dismutase deficiency exacerbates cerebral infarction after focal cerebral ischemia/reperfusion in mice: implications for the production and role of superoxide radicals. Stroke 2002, 33:809-815.
10. Zhang P., Anglade P., Hirsch E.C., Javoy-Agid F., Agid Y. Distribution of manganese-dependent superoxide dismutase in the human brain. Neuroscience 1994, 61:317-330.
11. Rosenblum J.S., Gilula N.B., Lerner R.A. On signal sequence polymorphisms and diseases of distribution. Proc Natl Acad Sci USA 1996, 93:4471-4473.
12. Sutton A., Imbert A., Igoudjil A., Descatoire V., Cazanave S., Pessayre D., et al. The manganese superoxide dismutase Ala16Val dimorphism modulates both mitochondrial import and mRNA stability. Pharmacogenet Genomics 2005, 15:311-319.
13. Kowalski M., Bielecka-Kowalska A., Oszajca K., Makandjou-Ola E., Jaworski P., Bartkowiak J., Szemraj J. Manganese superoxide dismutase (MnSOD) gene (Ala-9Val, Ile58Thr) polymorphism in patients with age-related macular degeneration (AMD). Med Sci Monit 2010, 16:CR190-CR196.
14. Farin F.M., Hitosis Y., Hallagan S.E., Kushleika J., Woods J.S., Janssen P.S., et al. Genetic polymorphisms of superoxide dismutase in Parkinson's disease. Mov Disord 2001, 16:705-707.
15. Singh M., Khan A.J., Shah P.P., Shukla R., Khanna V.K., Parmar D. Polymorphism in environment responsive genes and association with Parkinson disease. Mol Cell Biochem 2008, 312:131-138.
16. Hernandez-Saavedra D., McCord J.M. Paradoxical effects of thiol reagents on Jurkat cells and a new thiol-sensitive mutant form of human mitochondrial superoxide dismutase. Cancer Res 2003, 63:159-163.
17. Van Den Eeden S.K., Tanner C.M., Bernstein A.L., Fross R.D., Leimpeter A., Bloch D.A., et al. Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity. Am J Epidemiol 2003, 157:1015-1022.
18. Yoo M.S., Chun H.S., Son J.J., DeGiorgio L.A., Kim D.J., Peng C., et al. Oxidative stress regulated genes in nigral dopaminergic neuronal cells: correlation with the known pathology in Parkinson's disease. Brain Res Mol Brain Res 2003, 10:76-84.
19. Dawson T.M., Dawson V.L. Molecular pathways of neurodegeneration in Parkinson's disease. Science 2003, 302:819-822.
20. Testa C.M., Sherer T.B., Greenamyre J.T. Rotenone induces oxidative stress and dopaminergic neuron damage in organotypic substantia nigra cultures. Brain Res Mol Brain Res 2005, 134:109-118.
21. Kim A., Murphy M.P., Oberley T.D. Mitochondrial redox state regulates transcription of the nuclear-encoded mitochondrial protein manganese superoxide dismutase: a proposed adaptive response to mitochondrial redox imbalance. Free Radic Biol Med 2005, 38:644-654.
22. Dolgachev V., Oberley L.W., Huang T.T., Kraniak J.M., Tainsky M.A., Hanada K., et al. A role for manganese superoxide dismutase in apoptosis after photosensitization. Biochem Biophys Res Commun 2005, 332:411-417.
23. Martin R.C., Lan Q., Hughes K. A, Martini BD, Lissowska J, et al. No apparent association between genetic polymorphisms (-102 C>T) and (-9T>C) in the human manganese superoxide dismutase gene and gastric cancer. J Surg Res 2005, 124:92-97.
24. Zhang H.J., Yan T., Oberley T.D., Oberley L.W. Comparison of effects of two polymorphic variants of manganese superoxide dismutase on human breast MCF-7 cancer cell phenotype. Cancer Res 1999, 59:6276-6283.
25. Sutton A., Khoury H., Prip-Buus C., Cepanec C., Pessayre D., Degoul F. The Ala16Val genetic dimorphism modulates the import of human manganese superoxide dismutase into rat liver mitochondria. Pharmacogenetics 2003, 13:145-157.
26. Mikhak B., Hunter D.J., Spiegelman D., Platz E.A., Wu K., Erdman J.W., et al. Manganese superoxide dismutase (MnSOD) gene polymorphism, interactions with carotenoid levels and prostate cancer risk. Carcinogenesis 2008, 29:2335-2340.
27. Liu L., Zheng T., Wang N., Wang F., Li M., Jiang J., et al. The manganese superoxide dismutase Val16Ala polymorphism is associated with decreased risk of diabetic nephropathy in Chinese patients with type 2 diabetes. Mol Cell Biochem 2009, 322:87-91.
28. Nahon P., Charnaux N., Friand V., Prost-Squarcioni C., Ziol M., Lièvre N., et al. The manganese superoxide dismutase Ala16Val dimorphism modulates iron accumulation in human hepatoma cells. Free Radic Biol Med 2008, 45:1308-1317.
29. Rhodes S.L., Ritz B. Genetics of iron regulation and the possible role of iron in Parkinson's disease. Neurobiol Dis 2008, 32:183-195.
30. Fong C.S., Wu R.M., Shieh J.C., Chao Y.T., Fu Y.P., Kuao C.L., et al. Pesticide exposure on southwestern Taiwanese with MnSOD and NQO1 polymorphisms is associated with increased risk of Parkinson's disease. Clin Chim Acta 2007, 378:136-141.
31. Van Landeghem G.F., Tabatabaie P., Kucinskas V., Saha N., Beckman G. Ethnic variation in the mitochondrial targeting sequence polymorphism of MnSOD. Hum Hered 1999, 49:190-193.
32. Borgstahl G.E.O., Parge H.E., Hickey M.J., Johnson M.J., Boissinot M., Hallewell R.A., et al. Human mitochondrial manganese superoxide dismutase polymorphic variant Ile58Thr reduces activity by destabilizing the tetrameric interface. Biochemistry 1996, 35:4287-4297.
33. Chen RC, Chang SF, Su CL, Chen TH, Yen MF, Wu HM, Chen ZY, Liou HH. Prevalence, incidence, and mortality of PD: a door-to-door survey in Ilan county, Taiwan. Neurology 200;57:1679-86.
34. Wang V., Chia L.G., Ni D.R., Cheng L.J., Ho Y.P., Cheng F.C., et al. Effects of the combined treatment of naloxone and indomethacin on catecholamines and behavior after intranigral lipopolysaccharide injection. Neurochem Res 2004, 29:341-346.
35. Pezzini A., Grassi M., Del Zotto E., Lodigiani C., Ferrazzi P., Spalloni A., et al. Common genetic markers and prediction of recurrent events after ischemic stroke in young adults. Neurology 2009, 73:717-723.
36. Burack M.A., Hartlein J., Flores H.P., Taylor-Reinwald L., Perlmutter J.S., Cairns N.J. In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia. Neurology 2010, 74:77-84.
37. Maraganore D.M., de Andrade M., Lesnick T.G., Strain K.J., Farrer M.J., Rocca W.A., et al. High-resolution whole-genome association study of Parkinson disease. Am J Hum Genet 2005, 77:685-693.